This topic contains a solution. Click here to go to the answer

Author Question: Which is NOT part of sensitivity analysis for the transportation problem? a.changing the objective ... (Read 38 times)

mpobi80

  • Hero Member
  • *****
  • Posts: 519
Which is NOT part of sensitivity analysis for the transportation problem?
  a.changing the objective function coefficient of a basic variable.
  b.increasing a single supply by and a single demand by .
  c.increasing a single supply by and decreasing a single demand by .
  d.changing the objective function coefficient of a nonbasic variable.

Question 2

For a minimum transportation problem the bfs is optimal if:
  a.ui + vj - cij0 for all nonbasic variables.
  b.ui + vj - cij0 for all basic variables.
  c.ui + vj - cij0 for all nonbasic variables.
  d.ui + vj - cij0 for all basic variables.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

katieost

  • Sr. Member
  • ****
  • Posts: 358
Answer to Question 1

correct: c

Answer to Question 2

correct: c



mpobi80

  • Hero Member
  • *****
  • Posts: 519
Both answers were spot on, thank you once again




 

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

According to research, pregnant women tend to eat more if carrying a baby boy. Male fetuses may secrete a chemical that stimulates their mothers to step up her energy intake.

Did you know?

Certain rare plants containing cyanide include apricot pits and a type of potato called cassava. Fortunately, only chronic or massive ingestion of any of these plants can lead to serious poisoning.

Did you know?

Although not all of the following muscle groups are commonly used, intramuscular injections may be given into the abdominals, biceps, calves, deltoids, gluteals, laterals, pectorals, quadriceps, trapezoids, and triceps.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library